Inventor · disambiguated record
Thomas Francois Durand-Reville
Also filed as: DURAND-REVILLE THOMAS · DURAND-REVILLE THOMAS F · DURAND-REVILLE THOMAS FRANCOIS
6 granted patents·4 pending applications·17 citations·filing 2005–2023
77Inventor score
Files withENTASIS THERAPEUTICS LTD5BIOGEN IDEC INC1CUERVO JULIO HERMAN1DURAND REVILLE THOMAS FRANCOIS1ENTASIS THERAPEUTICS INC1
Top patents by PatentIndex Score
10 records- 0183US10800778B2Beta-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2017·Granted Oct 13, 2020·4 cites·25 claims
- 0281US9968593B2Combination therapy for treatment of resistant bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2015·Granted May 15, 2018·4 cites·8 claims
- 0380US10376499B2Combination therapy for treatment of resistant bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2018·Granted Aug 13, 2019·3 cites·9 claims
- 0476US9309245B2Beta-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2013·Granted Apr 12, 2016·4 cites·20 claims
- 0573US9623014B2β-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2016·Granted Apr 18, 2017·2 cites·22 claims
- 0656US2025368644A1Durlobactam crystalline formsDURAND REVILLE THOMAS FRANCOIS·Filed 2023·Application pending·0 cites
- 0745US2011021513A1Modulators of interleukin-1 receptor-associated kinaseBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 0841US2007259863A1Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide DerivativesICOS CORP·Filed 2005·Application pending·0 cites
- 0936US2009036650A1Compounds and methods for peptide synthesisCUERVO JULIO HERMAN·Filed 2006·Application pending·0 cites
- 1033US11046694B2Compounds and methods for treating bacterial infectionsENTASIS THERAPEUTICS INC·Filed 2018·Granted Jun 29, 2021·0 cites·26 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →